Cosio S - Search Results

1

Is Perineural Invasion a Novel Prognostic Factor Useful to Tailor Adjuvant Treatment in Patients Treated With Primary Surgery for Cervical and Vulvar Carcinoma?

Gadducci A, Pistolesi S, Cosio S, Naccarato AG. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2020 Jun;40(6):3031-3037. doi: 10.21873/anticanres.14283. Anticancer Res. 2020. PMID: 32487596 Review.

2

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study.

Buttitta F, Marchetti A, Gadducci A, Pellegrini S, Morganti M, Carnicelli V, Cosio S, Gagetti O, Genazzani AR, Bevilacqua G. Buttitta F, et al. Among authors: cosio s. Br J Cancer. 1997;75(2):230-5. doi: 10.1038/bjc.1997.38. Br J Cancer. 1997. PMID: 9010031 Free PMC article.

3

Hormone replacement therapy and gynecological cancer.

Gadducci A, Fanucchi A, Cosio S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1997 Sep-Oct;17(5B):3793-8. Anticancer Res. 1997. PMID: 9427782 Review.

4

Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.

Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Cosio S, Prontera C, Bianchi R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1997 Nov-Dec;17(6D):4463-6. Anticancer Res. 1997. PMID: 9494551

5

Platinum compounds and paclitaxel in advanced epithelial ovarian cancer.

Gadducci A, Brunetti I, Cosio S, Giannessi PG, Genazzani AR, Conte P. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1997 Nov-Dec;17(6D):4703-8. Anticancer Res. 1997. PMID: 9494592 Review.

6

Analysis of failures after negative second-look in patients with advanced ovarian cancer: an Italian multicenter study.

Gadducci A, Sartori E, Maggino T, Zola P, Landoni F, Fanucchi A, Palai N, Alessi C, Ferrero AM, Cosio S, Cristofani R. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 1998 Feb;68(2):150-5. doi: 10.1006/gyno.1997.4890. Gynecol Oncol. 1998. PMID: 9514797

7

The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.

Gadducci A, Ferdeghini M, Cosio S, Annicchiarico C, Fanucchi A, Prontera C, Bianchi R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1998 Jan-Feb;18(1B):537-9. Anticancer Res. 1998. PMID: 9568174

8

Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma.

Gadducci A, Ferdeghini M, Buttitta F, Cosio S, Fanucchi A, Annicchiarico C, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1998 Sep-Oct;18(5B):3763-5. Anticancer Res. 1998. PMID: 9854491

9

Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer.

Gadducci A, Ferdeghini M, Buttitta F, Cosio S, Fanucchi A, Annicchiarico C, Gagetti O, Bevilacqua G, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 1999 Jan;72(1):76-81. doi: 10.1006/gyno.1998.5101. Gynecol Oncol. 1999. PMID: 9889034

10

Preoperative serum E-cadherin assay in patients with ovarian carcinoma.

Gadducci A, Ferdeghini M, Cosio S, Annicchiarico C, Ciampi B, Bianchi R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1999 Jan-Feb;19(1B):769-72. Anticancer Res. 1999. PMID: 10216491

11

Combination of cisplatin, epirubicin, and cyclophosphamide (PEC regimen) in advanced or recurrent endometrial cancer: a retrospective clinical study.

Gadducci A, Romanini A, Cosio S, Fanucchi A, Tanganelli L, Ciampi B, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1999 May-Jun;19(3B):2253-6. Anticancer Res. 1999. PMID: 10472339

12

Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.

Gadducci A, Iacconi P, Fanucchi A, Cosio S, Teti G, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2000 May-Jun;20(3B):1959-64. Anticancer Res. 2000. PMID: 10928134

13

An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.

Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2000 May-Jun;20(3B):1977-84. Anticancer Res. 2000. PMID: 10928137

14

Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.

Gadducci A, Iacconi P, Cosio S, Fanucchi A, Cristofani R, Riccardo Genazzani A. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 2000 Dec;79(3):344-9. doi: 10.1006/gyno.2000.5992. Gynecol Oncol. 2000. PMID: 11104603

15

p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen.

Gadducci A, Cianci C, Cosio S, Carnino F, Fanucchi A, Buttitta F, Conte PF, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2000 Nov-Dec;20(6C):4793-9. Anticancer Res. 2000. PMID: 11205220

16

Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.

Gadducci A, Landoni F, Sartori E, Maggino T, Zola P, Gabriele A, Rossi R, Cosio S, Fanucchi A, Tisi G. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 2001 May;81(2):150-9. doi: 10.1006/gyno.2001.6134. Gynecol Oncol. 2001. PMID: 11330942

17

The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer.

Gadducci A, Ferdeghini M, Cosio S, Fanucchi A, Cristofani R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Int J Gynecol Cancer. 2001 Jul-Aug;11(4):277-82. doi: 10.1046/j.1525-1438.2001.011004277.x. Int J Gynecol Cancer. 2001. PMID: 11520365

18

Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management.

Gadducci A, Cosio S, Fanucchi A, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2001 Jul-Aug;21(4B):2941-7. Anticancer Res. 2001. PMID: 11712791 Review.

19

Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of advanced cervical cancer.

Gadducci A, Cosio S, Cionini L, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2001 Sep-Oct;21(5):3525-33. Anticancer Res. 2001. PMID: 11848519 Review.

20

The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.

Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Cosio S, Tisi G, Lissoni A, Ferrero AM, Cristofani R. Gadducci A, et al. Among authors: cosio s. Eur J Gynaecol Oncol. 2002;23(4):295-9. Eur J Gynaecol Oncol. 2002. PMID: 12214727

21

Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications.

Gadducci A, Cosio S, Muraca S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Eur J Gynaecol Oncol. 2002;23(5):390-6. Eur J Gynaecol Oncol. 2002. PMID: 12440809 Review.

22

Renal impairment in patients with ovarian cancer.

Donadio C, Lucchesi A, Ardini M, Cosio S, Gadducci A. Donadio C, et al. Among authors: cosio s. Eur J Obstet Gynecol Reprod Biol. 2003 Feb 10;106(2):198-202. doi: 10.1016/s0301-2115(02)00234-8. Eur J Obstet Gynecol Reprod Biol. 2003. PMID: 12551792

23

Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma.

Buttitta F, Pellegrini C, Marchetti A, Gadducci A, Cosio S, Felicioni L, Barassi F, Salvatore S, Martella C, Coggi G, Bosari S. Buttitta F, et al. Among authors: cosio s. J Clin Oncol. 2003 Apr 1;21(7):1320-5. doi: 10.1200/JCO.2003.09.065. J Clin Oncol. 2003. PMID: 12663721

24

Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma.

Gadducci A, Viacava P, Cosio S, Fanelli G, Fanucchi A, Cecchetti D, Cristofani R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2003 Jan-Feb;23(1B):549-56. Anticancer Res. 2003. PMID: 12680144

25

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients.

Romanini A, Tanganelli L, Carnino F, Fanucchi A, Lionetto R, Pastorino S, Cosio S, Gadducci A, Conte PF. Romanini A, et al. Among authors: cosio s. Gynecol Oncol. 2003 Jun;89(3):354-9. doi: 10.1016/s0090-8258(03)00128-8. Gynecol Oncol. 2003. PMID: 12798695 Clinical Trial.

26

The management of malignant nondysgerminomatous ovarian germ cell tumors.

Gadducci A, Cosio S, Muraca S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2003 Mar-Apr;23(2C):1827-36. Anticancer Res. 2003. PMID: 12820465 Review.

27

Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma.

Gadducci A, Viacava P, Cosio S, Cecchetti D, Fanelli G, Fanucchi A, Teti G, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2003 May-Jun;23(3C):3001-8. Anticancer Res. 2003. PMID: 12926153

28

Is pretreatment hemoglobin level a predictor of complete response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma?

Gadducci A, Cosio S, Fanucchi A, Tanganelli L, Conte PF, Cristofani R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Eur J Gynaecol Oncol. 2003;24(5):405-10. Eur J Gynaecol Oncol. 2003. PMID: 14584657

29

The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study.

Gadducci A, Sartori E, Maggino T, Landoni F, Zola P, Cosio S, Pasinetti B, Alessi C, Maneo A, Ferrero A. Gadducci A, et al. Among authors: cosio s. Eur J Gynaecol Oncol. 2003;24(6):513-6. Eur J Gynaecol Oncol. 2003. PMID: 14658592

30

Serum tumor markers in the management of ovarian, endometrial and cervical cancer.

Gadducci A, Cosio S, Carpi A, Nicolini A, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Biomed Pharmacother. 2004 Jan;58(1):24-38. doi: 10.1016/j.biopha.2003.11.003. Biomed Pharmacother. 2004. PMID: 14739059 Review.

31

Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature.

Gadducci A, Cosio S, Fanucchi A, Nardini V, Roncella M, Conte PF, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2003 Nov-Dec;23(6D):5225-9. Anticancer Res. 2003. PMID: 14981994 Review.

32

The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma.

Gadducci A, Cosio S, Fanucchi A, Negri S, Cristofani R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 2004 Apr;93(1):131-6. doi: 10.1016/j.ygyno.2003.12.043. Gynecol Oncol. 2004. PMID: 15047226

33

Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body.

Gadducci A, Cosio S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Curr Opin Investig Drugs. 2004 Oct;5(10):1031-44. Curr Opin Investig Drugs. 2004. PMID: 15535424 Review.

34

Relationship between time interval from primary surgery to the start of taxane- plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study.

Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Maggioni A, Cosio S, Frassi E, LaPresa MT, Fuso L, Cristofani R. Gadducci A, et al. Among authors: cosio s. J Clin Oncol. 2005 Feb 1;23(4):751-8. doi: 10.1200/JCO.2005.03.065. Epub 2004 Dec 21. J Clin Oncol. 2005. PMID: 15613698 Free article.

35

Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data.

Gadducci A, Cosio S, Gargini A, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Gynecol Endocrinol. 2004 Oct;19(4):216-28. doi: 10.1080/09513590400014354. Gynecol Endocrinol. 2004. PMID: 15724805 Review. No abstract available.

36

Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature.

Gadducci A, Cosio S, Conte PF, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2005 Aug;55(2):153-66. doi: 10.1016/j.critrevonc.2005.03.003. Crit Rev Oncol Hematol. 2005. PMID: 15890524 Review.

37

Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.

Gadducci A, Cosio S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2006 Jun;58(3):242-56. doi: 10.1016/j.critrevonc.2005.11.002. Epub 2006 Jan 24. Crit Rev Oncol Hematol. 2006. PMID: 16436330 Review.

38

P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome.

Gadducci A, Di Cristofano C, Zavaglia M, Giusti L, Menicagli M, Cosio S, Naccarato AG, Genazzani AR, Bevilacqua G, Cavazzana AO. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2006 Jan-Feb;26(1B):687-93. Anticancer Res. 2006. PMID: 16739339 Free article.

39

Intratumoral microvessel density in advanced epithelial ovarian cancer and its use as a prognostic variable.

Gadducci A, Ferrero A, Cosio S, Zola P, Viacava P, Dompé D, Fanelli G, Ravarino N, Motta M, Cristofani R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2006 Sep-Oct;26(5B):3925-32. Anticancer Res. 2006. PMID: 17094423 Free article.

40

Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature.

Gadducci A, Cosio S, Zola P, Landoni F, Maggino T, Sartori E. Gadducci A, et al. Among authors: cosio s. Int J Gynecol Cancer. 2007 Jan-Feb;17(1):21-31. doi: 10.1111/j.1525-1438.2007.00826.x. Int J Gynecol Cancer. 2007. PMID: 17291227 Review.

41

Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study).

Landoni F, Zanagnolo V, Lovato-Diaz L, Maneo A, Rossi R, Gadducci A, Cosio S, Maggino T, Sartori E, Tisi C, Zola P, Marocco F, Botteri E, Ravanelli K; Cooperative Task Force. Landoni F, et al. Among authors: cosio s. Int J Gynecol Cancer. 2007 May-Jun;17(3):623-8. doi: 10.1111/j.1525-1438.2006.00854.x. Epub 2007 Feb 16. Int J Gynecol Cancer. 2007. PMID: 17309669

42

The management of patients with uterine sarcoma: a debated clinical challenge.

Gadducci A, Cosio S, Romanini A, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2008 Feb;65(2):129-42. doi: 10.1016/j.critrevonc.2007.06.011. Epub 2007 Aug 13. Crit Rev Oncol Hematol. 2008. PMID: 17706430 Review.

43

Ovarian function and childbearing issues in breast cancer survivors.

Gadducci A, Cosio S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Gynecol Endocrinol. 2007 Nov;23(11):625-31. doi: 10.1080/09513590701582406. Gynecol Endocrinol. 2007. PMID: 17926162 Review.

44

The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.

Gadducci A, Tana R, Cosio S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2008 Apr;66(1):10-20. doi: 10.1016/j.critrevonc.2007.09.002. Epub 2007 Oct 26. Crit Rev Oncol Hematol. 2008. PMID: 17964182 Review.

45

Molecular target therapies in endometrial cancer: from the basic research to the clinic.

Gadducci A, Tana R, Cosio S, Fanucchi A, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Gynecol Endocrinol. 2008 May;24(5):239-49. doi: 10.1080/09513590801953556. Gynecol Endocrinol. 2008. PMID: 18569027 Review.

46

Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.

Gadducci A, Cosio S, Tana R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2009 Jan;69(1):12-27. doi: 10.1016/j.critrevonc.2008.05.001. Epub 2008 Jul 1. Crit Rev Oncol Hematol. 2009. PMID: 18595727 Review.

47

Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer.

Donadio C, Lucchesi A, Ardini M, Cosio S, Fanucchi A, Gadducci A. Donadio C, et al. Among authors: cosio s. Ther Drug Monit. 2009 Feb;31(1):63-9. doi: 10.1097/FTD.0b013e3181947812. Ther Drug Monit. 2009. PMID: 19077927

48

Surveillance of patients after initial treatment of ovarian cancer.

Gadducci A, Cosio S. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2009 Jul;71(1):43-52. doi: 10.1016/j.critrevonc.2008.12.008. Crit Rev Oncol Hematol. 2009. PMID: 19179092 Review.

49

The perioperative management of patients with gynaecological cancer undergoing major surgery: A debated clinical challenge.

Gadducci A, Cosio S, Spirito N, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2010 Feb;73(2):126-40. doi: 10.1016/j.critrevonc.2009.02.008. Epub 2009 Apr 7. Crit Rev Oncol Hematol. 2010. PMID: 19356947 Review.

50

Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study.

Gadducci A, Fuso L, Cosio S, Landoni F, Maggino T, Perotto S, Sartori E, Testa A, Galletto L, Zola P. Gadducci A, et al. Among authors: cosio s. Int J Gynecol Cancer. 2009 Apr;19(3):367-74. doi: 10.1111/IGC.0b013e3181a1cc02. Int J Gynecol Cancer. 2009. PMID: 19407561

51

Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.

Gadducci A, Cavazzana A, Cosio S, DI Cristofano C, Tana R, Fanucchi A, Teti G, Cristofani R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2009 May;29(5):1715-20. Anticancer Res. 2009. PMID: 19443392 Free article.

52

Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.

Pecorelli S, Favalli G, Gadducci A, Katsaros D, Panici PB, Carpi A, Scambia G, Ballardini M, Nanni O, Conte P; After 6 Italian Cooperative Group. Pecorelli S, et al. J Clin Oncol. 2009 Oct 1;27(28):4642-8. doi: 10.1200/JCO.2009.21.9691. Epub 2009 Aug 24. J Clin Oncol. 2009. PMID: 19704064 Clinical Trial.

53

Evolving role of serum biomarkers in the management of ovarian cancer.

Gadducci A, Cosio S, Zanca G, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Womens Health (Lond). 2006 Jan;2(1):141-58. doi: 10.2217/17455057.2.1.141. Womens Health (Lond). 2006. PMID: 19803934 Free article.

54

Clinical outcome of tailored adjuvant postoperative chemoradiotherapy in IB FIGO stage cervical cancer.

Fabrini MG, Gadducci A, Perrone F, Cosio S, Laliscia C, Pasqualetti F, Grespi S, Cionini L. Fabrini MG, et al. Among authors: cosio s. Anticancer Res. 2009 Oct;29(10):4205-10. Anticancer Res. 2009. PMID: 19846974 Free article.

55

Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.

Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Gynecol Endocrinol. 2009 Dec;25(12):807-15. doi: 10.3109/09513590903056878. Gynecol Endocrinol. 2009. PMID: 19906000 Review.

56

The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study.

Gadducci A, Cosio S, Zola P, Sostegni B, Ferrero AM, Teti G, Cristofani R, Sartori E. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 2010 Mar;116(3):358-63. doi: 10.1016/j.ygyno.2009.11.008. Epub 2009 Dec 1. Gynecol Oncol. 2010. PMID: 19954826

57

Clear cell carcinoma of the endometrium: a biological and clinical enigma.

Gadducci A, Cosio S, Spirito N, Cionini L. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2010 Apr;30(4):1327-34. Anticancer Res. 2010. PMID: 20530448 Review.

58

Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.

Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Gynecol Endocrinol. 2010 Aug;26(8):568-77. doi: 10.3109/09513590.2010.487609. Gynecol Endocrinol. 2010. PMID: 20632911 Review.

59

Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.

Gadducci A, Cosio S, Zola P, Tisi G, Ferrero A, Piovano E, Cristofani R, Greco C, Sartori E. Gadducci A, et al. Among authors: cosio s. Int J Gynecol Cancer. 2010 Nov;20(8):1399-404. doi: 10.1111/IGC.0b013e3181f1574e. Int J Gynecol Cancer. 2010. PMID: 21051984

60

Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer.

Gadducci A, Cosio S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2011 Nov;80(2):181-92. doi: 10.1016/j.critrevonc.2010.11.005. Epub 2010 Dec 4. Crit Rev Oncol Hematol. 2011. PMID: 21134766 Review.

61

Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature.

Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo Genazzani A. Gadducci A, et al. Among authors: cosio s. Gynecol Endocrinol. 2011 Aug;27(8):597-604. doi: 10.3109/09513590.2011.558953. Epub 2011 Mar 25. Gynecol Endocrinol. 2011. PMID: 21438669 Review.

62

p53 nuclear accumulation in preneoplastic lesions and stage I uterine endometrioid adenocarcinoma.

Buttitta F, Marchetti A, Athanassiadou S, Gadducci A, Bellina S, Cosio S, Mancini F, Genazzani A, Bevilacqua G. Buttitta F, et al. Among authors: cosio s. Oncol Rep. 1997 Mar-Apr;4(2):315-8. doi: 10.3892/or.4.2.315. Oncol Rep. 1997. PMID: 21590050

63

Patterns of failures in endometrial cancer: clinicopathological variables predictive of the risk of local, distant and retroperitoneal failure.

Gadducci A, Cosio S, Fabrini MG, Fanucchi A, Barsotti C, Cristofani R, Greco C, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2011 Oct;31(10):3483-8. Anticancer Res. 2011. PMID: 21965765

64

Relationship between interval from surgery to radiotherapy and local recurrence rate in patients with endometrioid-type endometrial cancer: a retrospective mono-institutional Italian study.

Fabrini MG, Gadducci A, Perrone F, La Liscia C, Cosio S, Moda S, Guerrieri ME, Grandinetti A, Greco C. Fabrini MG, et al. Among authors: cosio s. Anticancer Res. 2012 Jan;32(1):169-73. Anticancer Res. 2012. PMID: 22213303 Clinical Trial.

65

Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer.

Gadducci A, Cosio S, Fabrini MG, Guerrieri ME, Greco C, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2012 Jan;32(1):201-5. Anticancer Res. 2012. PMID: 22213308

66

Treatment options in recurrent cervical cancer (Review).

Gadducci A, Tana R, Cosio S, Cionini L. Gadducci A, et al. Among authors: cosio s. Oncol Lett. 2010 Jan;1(1):3-11. doi: 10.3892/ol_00000001. Epub 2010 Jan 1. Oncol Lett. 2010. PMID: 22966247 Free PMC article.

67

Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.

Gadducci A, Cosio S, Landoni F, Maggino T, Zola P, Fuso L, Sartori E. Gadducci A, et al. Among authors: cosio s. Int J Gynecol Cancer. 2012 Oct;22(8):1355-60. doi: 10.1097/IGC.0b013e318267f7a0. Int J Gynecol Cancer. 2012. PMID: 22976496

68

Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.

Gadducci A, Cosio S, Zola P, Sostegni B, Fuso L, Sartori E. Gadducci A, et al. Among authors: cosio s. Int J Gynecol Cancer. 2013 Mar;23(3):461-8. doi: 10.1097/IGC.0b013e318286665b. Int J Gynecol Cancer. 2013. PMID: 23370604

69

Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study).

Gadducci A, Sartori E, Maggino T, Zola P, Cosio S, Zizioli V, Lapresa M, Piovano E, Landoni F. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 2013 Dec;131(3):640-4. doi: 10.1016/j.ygyno.2013.09.029. Epub 2013 Oct 3. Gynecol Oncol. 2013. PMID: 24096111

70

Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.

Landoni F, Sartori E, Maggino T, Zola P, Zanagnolo V, Cosio S, Ferrari F, Piovano E, Gadducci A. Landoni F, et al. Among authors: cosio s. Gynecol Oncol. 2014 Mar;132(3):611-7. doi: 10.1016/j.ygyno.2013.12.010. Epub 2013 Dec 14. Gynecol Oncol. 2014. PMID: 24342439

71

Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study).

Gadducci A, Cosio S, Landoni F, Maggino T, Zola P, Sostegni B, Bellicini A, Fuso L, Cristofani R, Sartori E. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 2014 Jul;134(1):29-35. doi: 10.1016/j.ygyno.2014.04.008. Epub 2014 Apr 24. Gynecol Oncol. 2014. PMID: 24769176 Free article.

72

Correlation between CA125 levels after sixth cycle of chemotherapy and clinical outcome in advanced ovarian carcinoma.

Gadducci A, Menichetti A, Guiggi I, Notarnicola M, Cosio S. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2015 Feb;35(2):1099-104. Anticancer Res. 2015. PMID: 25667499

73

Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.

Gadducci A, Lanfredini N, Cosio S. Gadducci A, et al. Among authors: cosio s. Gynecol Endocrinol. 2015;31(9):673-8. doi: 10.3109/09513590.2015.1054803. Epub 2015 Aug 18. Gynecol Endocrinol. 2015. PMID: 26288335 Review.

74

Has serum CA 125 assay at the time of relapse a prognostic relevance for patients with recurrent ovarian carcinoma after primary cytoreduction and platinum- and paclitaxel-based chemotherapy?

Gadducci A, Notarnicola M, Menichetti A, Lanfredini N, Fanucchi A, Cosio S. Gadducci A, et al. Among authors: cosio s. Eur J Gynaecol Oncol. 2016;37(2):182-8. Eur J Gynaecol Oncol. 2016. PMID: 27172742

75

Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy.

Gadducci A, Cosio S, Fanucchi A, Tana R, Manacorda S, Pistolesi S, Strigini FL. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2016 Jul;36(7):3477-82. Anticancer Res. 2016. PMID: 27354611

76

Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.

Gadducci A, Biglia N, Tana R, Cosio S, Gallo M. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2016 Sep;105:73-83. doi: 10.1016/j.critrevonc.2016.06.006. Epub 2016 Jun 18. Crit Rev Oncol Hematol. 2016. PMID: 27378194 Review.

77

Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study.

Gadducci A, Cosio S, Zizioli V, Notaro S, Tana R, Panattoni A, Sartori E. Gadducci A, et al. Among authors: cosio s. Int J Gynecol Cancer. 2017 Jan;27(1):28-36. doi: 10.1097/IGC.0000000000000843. Int J Gynecol Cancer. 2017. PMID: 27870700

78

Dose-dense Paclitaxel- and Carboplatin-based Neoadjuvant Chemotherapy Followed by Surgery or Concurrent Chemo-radiotherapy in Cervical Cancer: a Preliminary Analysis.

Gadducci A, Barsotti C, Laliscia C, Cosio S, Fanucchi A, Tana R, Fabrini MG. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2017 Mar;37(3):1249-1255. doi: 10.21873/anticanres.11441. Anticancer Res. 2017. PMID: 28314289

79

Rates, Sites and Times of Recurrence and Clinical Outcome of Endometrial Cancer Patients with Histologically-positive Nodes: An Italian Two-center Retrospective Study.

Gadducci A, Guerrieri ME, Cosio S, Fabrini MG, Laliscia C, Attianese D, Rossi A, Ferrero A. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2018 Mar;38(3):1695-1703. doi: 10.21873/anticanres.12403. Anticancer Res. 2018. PMID: 29491104

80

Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.

Gadducci A, Landoni F, Cosio S, Zizioli V, Zola P, Ferrero AM, Lapresa MT, Maggino T, Sartori E. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2018 Jun;38(6):3627-3634. doi: 10.21873/anticanres.12637. Anticancer Res. 2018. PMID: 29848719 Free article.

81

Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.

Gadducci A, Pistolesi S, Guerrieri ME, Cosio S, Carbone FG, Naccarato AG. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2018 Jun;38(6):3669-3675. doi: 10.21873/anticanres.12644. Anticancer Res. 2018. PMID: 29848726 Review.

82

Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A challenging question for gynecologic oncologists.

Gadducci A, Guerrieri ME, Cosio S. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2019 Jan;133:92-98. doi: 10.1016/j.critrevonc.2018.10.005. Epub 2018 Nov 2. Crit Rev Oncol Hematol. 2019. PMID: 30661663 Review.

83

Novel targeted therapies in epithelial ovarian cancer: from basic research to the clinic.

Gadducci A, Cosio S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Expert Rev Endocrinol Metab. 2007 Mar;2(2):225-238. doi: 10.1586/17446651.2.2.225. Expert Rev Endocrinol Metab. 2007. PMID: 30754175

84

Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables.

Gadducci A, Guerrieri ME, Cosio S. Gadducci A, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2019 Mar;135:103-114. doi: 10.1016/j.critrevonc.2019.01.006. Epub 2019 Jan 19. Crit Rev Oncol Hematol. 2019. PMID: 30819439 Review.

85

Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy.

Laliscia C, Cosio S, Morganti R, Mazzotti V, Fabrini MG, Paiar F, Gadducci A. Laliscia C, et al. Among authors: cosio s. Oncology. 2019;96(5):235-241. doi: 10.1159/000492430. Epub 2019 Mar 22. Oncology. 2019. PMID: 30904907

86

Clinical Outcome of Patients With Malignant Tumors Associated With Mature Cystic Teratomas of the Ovary: A Retrospective Multicenter Italian Study.

Gadducci A, Giuliani D, Cosio S, Lissoni A, Ferrero AM, Landoni F. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2019 May;39(5):2513-2517. doi: 10.21873/anticanres.13372. Anticancer Res. 2019. PMID: 31092447

87

Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study.

Gadducci A, Cosio S, Lissoni AA, Zizioli V, Adorni M, Ferrero AM, Landoni F, Sartori E. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2020 Mar;40(3):1543-1550. doi: 10.21873/anticanres.14100. Anticancer Res. 2020. PMID: 32132055

88

Positron Emission Tomography/Computed Tomography in Platinum-sensitive Recurrent Ovarian Cancer: A Single-center Italian Study.

Gadducci A, Simonetti E, Manca G, Guidoccio F, Fanucchi A, Cosio S, Volterrani D. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2020 Apr;40(4):2191-2197. doi: 10.21873/anticanres.14180. Anticancer Res. 2020. PMID: 32234914

89

Therapeutic Approach to Low-Grade Serous Ovarian Carcinoma: State of Art and Perspectives of Clinical Research.

Gadducci A, Cosio S. Gadducci A, et al. Among authors: cosio s. Cancers (Basel). 2020 May 23;12(5):1336. doi: 10.3390/cancers12051336. Cancers (Basel). 2020. PMID: 32456205 Free PMC article. Review.

90

Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research.

Gadducci A, Cosio S. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2020 Sep;40(9):4819-4828. doi: 10.21873/anticanres.14485. Anticancer Res. 2020. PMID: 32878770 Review.

91

Pharmacological Treatment of Patients with Metastatic, Recurrent or Persistent Cervical Cancer Not Amenable by Surgery or Radiotherapy: State of Art and Perspectives of Clinical Research.

Gadducci A, Cosio S. Gadducci A, et al. Among authors: cosio s. Cancers (Basel). 2020 Sep 19;12(9):2678. doi: 10.3390/cancers12092678. Cancers (Basel). 2020. PMID: 32961781 Free PMC article. Review.

92

Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue.

Gadducci A, Cosio S, Fruzzetti F. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2020 Nov;40(11):5995-6002. doi: 10.21873/anticanres.14620. Anticancer Res. 2020. PMID: 33109537 Review.

93

The Prognostic Relevance of Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Gynecological Cancer.

Gadducci A, Cosio S. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2021 Jan;41(1):9-20. doi: 10.21873/anticanres.14747. Anticancer Res. 2021. PMID: 33419795 Review.

94

Dose-dense Neoadjuvant Chemotherapy With Paclitaxel and Carboplatin in Cervical Cancer: Efficacy on Pathological Response.

DI Martino G, Lissoni AA, Ferrari D, DI Meo ML, Cosio S, Gadducci A, Landoni F. DI Martino G, et al. Among authors: cosio s. Anticancer Res. 2021 Jan;41(1):497-502. doi: 10.21873/anticanres.14800. Anticancer Res. 2021. PMID: 33419848

95

A narrative review of pregnancy after malignancies in young women that don't originate in the female genital organs or in the breast.

Girardelli S, Mangili G, Cosio S, Rabaiotti E, Fanucchi A, Valsecchi L, Candiani M, Gadducci A. Girardelli S, et al. Among authors: cosio s. Crit Rev Oncol Hematol. 2021 Mar;159:103240. doi: 10.1016/j.critrevonc.2021.103240. Epub 2021 Jan 20. Crit Rev Oncol Hematol. 2021. PMID: 33484854 Review.

96

Perineural Invasion Correlates With Common Pathological Variables and Clinical Outcomes of Patients With Squamous Cell Carcinoma of the Vulva Treated With Primary Radical Surgery and Inguinal-femoral Lymphadenectomy.

Gadducci A, Pistolesi S, Cosio S, Comunale C, Fanucchi A, Naccarato AG. Gadducci A, et al. Among authors: cosio s. In Vivo. 2021 Mar-Apr;35(2):1051-1056. doi: 10.21873/invivo.12349. In Vivo. 2021. PMID: 33622901 Free PMC article.

97

Have Volume-based Parameters of Positron Emission Tomography/Computed Tomography Prognostic Relevance for Patients With Potentially Platinum-responsive Recurrent Ovarian Cancer? A Single Center Italian Study.

Gadducci A, Simonetti E, Guidoccio F, Manca G, Giorgetti A, Depalo T, Cosio S, Miccoli M, Volterrani D. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2021 Apr;41(4):1937-1944. doi: 10.21873/anticanres.14960. Anticancer Res. 2021. PMID: 33813399

98

Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes.

Gadducci A, Multinu F, Cosio S, Carinelli S, Ghioni M, Aletti GD. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 2021 Sep;162(3):741-750. doi: 10.1016/j.ygyno.2021.06.033. Epub 2021 Jul 8. Gynecol Oncol. 2021. PMID: 34247767 Review.

99

Primary Perivascular Epithelioid Cell Tumor (PEComa) of the Ovary: A Case Report and Review of the Literature.

Gadducci A, Ugolini C, Cosio S, Vistoli F, Kauffmann EF, Boggi U. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2021 Sep;41(9):4483-4488. doi: 10.21873/anticanres.15258. Anticancer Res. 2021. PMID: 34475073 Review.

100

Randomized Clinical Trials and Real World Prospective Observational Studies on Bevacizumab, PARP Inhibitors, and Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Ovarian Carcinoma: A Critical Review.

Gadducci A, Cosio S. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 2021 Oct;41(10):4673-4685. doi: 10.21873/anticanres.15281. Anticancer Res. 2021. PMID: 34593415 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page